IADSA update on international supplement regulations

Text/HTML

Recent AHPA Advocacy

EasyDNNNews

IADSA update on international supplement regulations

June 2022 IADSA Newsflash

Published: Thursday, June 16, 2022

AHPA is an active member of IADSA and is distributing the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash covers:

  • India is drafting a new regulatory framework addressing numerous products including health supplements and nutraceuticals.
  • Taiwan is proposing label warnings for fish oil and red yeast rice products.
  • Korea is proposing changes to its health function food code to add a function for ginseng and to remove aloe whole leaf.
  • The European Union (EU) is proposing a limit of 800 mg/day for epigallocatechin-3-gallate (ECCG) from green tea extracts, along with a warning label. No transition period is anticipated.
  • The EU is also limiting monacolins in red yeast rice products to dosages not exceeding 3 mg. Use of monacolins at lower levels has been put under scrutiny for 18 months.
  • Belgium has issue guidance on the determination of vitamin B12 in botanicals – use of a method selective for the active form of vitamin B12 is recommended.
  • Sweden has introduced a proposal for maximum limits on vitamin D and iodine.
  • United Kingdom (UK) has released a list of food items containing cannabidiol (CBD) as part of its process to formally recognize CBD products under a regulatory framework.
  • South Africa’s Supreme Court has determined that the regulation of health supplements under the complementary medicines regulations is unlawful – the South African Health Product Regulatory Agency has been given 12 months to propose a new framework.
  • Numerous Gulf states are moving to ban titanium dioxide in food products, following a similar ban in the EU.
  • Peru has updated its list of vitamins, minerals, and other nutrients allowed in dietary products.

Download the June 2022 issue >>

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.